Concepts (116)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostate | 7 | 2024 | 1773 | 0.830 |
Why?
|
| Cryosurgery | 4 | 2023 | 474 | 0.580 |
Why?
|
| Prostatic Neoplasms | 10 | 2024 | 11122 | 0.570 |
Why?
|
| Hypertension, Pulmonary | 5 | 2022 | 1578 | 0.350 |
Why?
|
| Carbonic Anhydrase Inhibitors | 2 | 2021 | 91 | 0.340 |
Why?
|
| Fatty Acid-Binding Proteins | 2 | 2021 | 296 | 0.280 |
Why?
|
| Pulmonary Artery | 3 | 2021 | 1927 | 0.200 |
Why?
|
| Ammonium Chloride | 1 | 2019 | 72 | 0.170 |
Why?
|
| Theory of Mind | 1 | 2021 | 91 | 0.170 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 4 | 1 | 2019 | 24 | 0.170 |
Why?
|
| Muscle, Smooth, Vascular | 3 | 2021 | 1492 | 0.170 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2019 | 28 | 0.170 |
Why?
|
| Acetazolamide | 1 | 2019 | 96 | 0.160 |
Why?
|
| Pregnancy-Associated Plasma Protein-A | 1 | 2019 | 60 | 0.160 |
Why?
|
| Carbonic Anhydrases | 1 | 2019 | 108 | 0.160 |
Why?
|
| Fenoterol | 1 | 2018 | 2 | 0.160 |
Why?
|
| Infant, Premature | 3 | 2018 | 2107 | 0.160 |
Why?
|
| Physical Conditioning, Animal | 1 | 2022 | 365 | 0.160 |
Why?
|
| Adipokines | 1 | 2021 | 310 | 0.160 |
Why?
|
| Tocolytic Agents | 1 | 2018 | 24 | 0.160 |
Why?
|
| Sympathomimetics | 1 | 2018 | 56 | 0.160 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2019 | 269 | 0.150 |
Why?
|
| PPAR gamma | 1 | 2021 | 484 | 0.150 |
Why?
|
| Vasodilation | 2 | 2021 | 962 | 0.140 |
Why?
|
| Fetal Macrosomia | 1 | 2017 | 141 | 0.130 |
Why?
|
| Nervous System Malformations | 1 | 2017 | 244 | 0.130 |
Why?
|
| Fibroblast Growth Factors | 1 | 2021 | 867 | 0.120 |
Why?
|
| Adiponectin | 1 | 2021 | 1113 | 0.120 |
Why?
|
| Isoenzymes | 1 | 2019 | 1687 | 0.120 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2017 | 461 | 0.120 |
Why?
|
| Biopsy | 2 | 2023 | 6766 | 0.110 |
Why?
|
| Gestational Age | 3 | 2018 | 3577 | 0.110 |
Why?
|
| Microcephaly | 1 | 2017 | 425 | 0.110 |
Why?
|
| Hemangioma | 1 | 2018 | 727 | 0.110 |
Why?
|
| Nitric Oxide | 2 | 2021 | 2135 | 0.100 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2016 | 326 | 0.100 |
Why?
|
| Birth Weight | 2 | 2018 | 2103 | 0.100 |
Why?
|
| Autistic Disorder | 1 | 2021 | 1220 | 0.100 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2019 | 1935 | 0.100 |
Why?
|
| Pre-Eclampsia | 1 | 2019 | 1231 | 0.090 |
Why?
|
| Placenta | 1 | 2019 | 1709 | 0.090 |
Why?
|
| Prostate-Specific Antigen | 3 | 2023 | 2469 | 0.080 |
Why?
|
| Anxiety | 1 | 2023 | 4573 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2021 | 8181 | 0.080 |
Why?
|
| Immunotherapy | 1 | 2023 | 4652 | 0.070 |
Why?
|
| Male | 19 | 2024 | 360842 | 0.070 |
Why?
|
| Rats | 5 | 2022 | 23741 | 0.070 |
Why?
|
| Research Design | 1 | 2023 | 6180 | 0.070 |
Why?
|
| Retrospective Studies | 7 | 2023 | 80646 | 0.070 |
Why?
|
| Vitamin D Deficiency | 1 | 2016 | 1388 | 0.070 |
Why?
|
| Ultrasonography, Interventional | 2 | 2024 | 1496 | 0.060 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2017 | 2151 | 0.060 |
Why?
|
| Infant, Newborn | 6 | 2019 | 26198 | 0.060 |
Why?
|
| Quality Improvement | 3 | 2023 | 3801 | 0.050 |
Why?
|
| Muscle Fibers, Fast-Twitch | 1 | 2022 | 70 | 0.050 |
Why?
|
| Vitamin D | 1 | 2016 | 3303 | 0.050 |
Why?
|
| Humans | 20 | 2024 | 761572 | 0.050 |
Why?
|
| Fetal Blood | 2 | 2019 | 1347 | 0.050 |
Why?
|
| Ablation Techniques | 1 | 2023 | 248 | 0.050 |
Why?
|
| Mesenteric Arteries | 1 | 2021 | 178 | 0.050 |
Why?
|
| Intelligence Tests | 1 | 2021 | 503 | 0.040 |
Why?
|
| Inhibins | 1 | 2019 | 210 | 0.040 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2022 | 542 | 0.040 |
Why?
|
| Hemodynamics | 2 | 2021 | 4160 | 0.040 |
Why?
|
| Tocolysis | 1 | 2018 | 18 | 0.040 |
Why?
|
| Contractile Proteins | 1 | 2019 | 240 | 0.040 |
Why?
|
| Case-Control Studies | 3 | 2021 | 22176 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2023 | 36429 | 0.040 |
Why?
|
| Acidosis | 1 | 2019 | 268 | 0.040 |
Why?
|
| Anti-Mullerian Hormone | 1 | 2019 | 407 | 0.040 |
Why?
|
| Macrophages, Alveolar | 1 | 2019 | 412 | 0.030 |
Why?
|
| Pregnancy | 4 | 2019 | 29876 | 0.030 |
Why?
|
| Glycolysis | 1 | 2021 | 835 | 0.030 |
Why?
|
| Cyclic GMP | 1 | 2017 | 395 | 0.030 |
Why?
|
| Fibronectins | 1 | 2019 | 723 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2017 | 656 | 0.030 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2019 | 699 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2019 | 1699 | 0.030 |
Why?
|
| Perception | 1 | 2021 | 1197 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2023 | 9280 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2019 | 1334 | 0.030 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2016 | 407 | 0.030 |
Why?
|
| United States Food and Drug Administration | 1 | 2022 | 1664 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2023 | 64684 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2023 | 8528 | 0.020 |
Why?
|
| Animals | 5 | 2022 | 168467 | 0.020 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2018 | 846 | 0.020 |
Why?
|
| Brain | 1 | 2017 | 27120 | 0.020 |
Why?
|
| Hospice Care | 1 | 2017 | 678 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 3810 | 0.020 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2017 | 1755 | 0.020 |
Why?
|
| Mothers | 1 | 2019 | 2198 | 0.020 |
Why?
|
| Pain | 1 | 2023 | 5073 | 0.020 |
Why?
|
| Female | 7 | 2021 | 392686 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2022 | 4948 | 0.020 |
Why?
|
| Protein Binding | 1 | 2019 | 9353 | 0.020 |
Why?
|
| Boston | 1 | 2019 | 9326 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2022 | 7967 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2023 | 54426 | 0.020 |
Why?
|
| Adult | 4 | 2021 | 221203 | 0.010 |
Why?
|
| Heart Diseases | 1 | 2017 | 2781 | 0.010 |
Why?
|
| Macrophages | 1 | 2019 | 5769 | 0.010 |
Why?
|
| Middle Aged | 3 | 2024 | 220920 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2019 | 12794 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2019 | 11530 | 0.010 |
Why?
|
| Logistic Models | 1 | 2016 | 13255 | 0.010 |
Why?
|
| Aged | 2 | 2024 | 169310 | 0.010 |
Why?
|
| Phenotype | 1 | 2017 | 16592 | 0.010 |
Why?
|
| Inflammation | 1 | 2019 | 10773 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 18253 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 26127 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2018 | 41493 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2017 | 23447 | 0.010 |
Why?
|
| Infant | 1 | 2016 | 36192 | 0.010 |
Why?
|
| Young Adult | 1 | 2021 | 59255 | 0.010 |
Why?
|
| United States | 1 | 2022 | 72335 | 0.010 |
Why?
|
Concepts
(116)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(18)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_